Preliminary data suggests a probable effect of HIV on myocardial fibrosis and steatosis in women, with inflammation being a key driver of fibrosis and metabolic dysfunction.
The primary objective of this study is to characterize myocardial fibrosis burden and identify novel infectious/immunologic predictors of progression among women with HIV on ART, in Sub-Saharan Africa. The study also aims to quantify myocardial steatosis burden and identify predictors of progression among women with HIV on ART, in Sub-Saharan Africa.
